SCHEMBL30288409

SCHEMBL30288409

CCOc1cccc(C(=O)OC)c1N

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
HCRTR1 O43613 2/20 0.50
HSD17B10 Q99714 2/20 0.50
CFTR P13569 1/20 0.50
KCNK3 O14649 1/20 0.48
KCNK9 Q9NPC2 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
MAPT P10636 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
LMNA P02545 1/20 0.47
HTT P42858 1/20 0.47
GAA P10253 2/20 0.47
GLA P06280 2/20 0.47
KDM4E B2RXH2 1/20 0.47
HPGD P15428 1/20 0.47
CASP1 P29466 1/20 0.47
CASP7 P55210 1/20 0.47
KMT2A Q03164 2/20 0.46
MAPK1 P28482 1/20 0.44
GRM5 P41594 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24009066 1.00 ALDH1A1 (0.50) ALDH1A1HCRTR1HSD17B10CFTRKCNK3
SCHEMBL23294932 0.87 ALDH1A1 (0.58) ALDH1A1HCRTR1HSD17B10MAPTL3MBTL1
SCHEMBL26696240 0.86 MAPT (0.51) ALDH1A1HSD17B10CFTRTDP1MAPT
SCHEMBL24009070 0.86 ALDH1A1 (0.49) ALDH1A1HSD17B10CFTRMAPTL3MBTL1
SCHEMBL10911414 0.83 CYP3A4 (0.51) ALDH1A1HCRTR1HSD17B10KCNK3KCNK9
SCHEMBL1320478 0.83 L3MBTL1 (0.50) ALDH1A1HCRTR1HSD17B10KCNK3KCNK9
SCHEMBL7534598 0.83 CYP3A4 (0.50) ALDH1A1HCRTR1KCNK3KCNK9MAPT
SCHEMBL1004686 0.83 HSD17B10 (0.56) ALDH1A1HSD17B10CFTRKCNK3KCNK9
SCHEMBL1989129 0.83 HCRTR1 (0.65) ALDH1A1HCRTR1KCNK3KCNK9TDP1
SCHEMBL30553984 0.83 HCRTR1 (0.65) ALDH1A1HCRTR1KCNK3KCNK9TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4146344-A1 IMINO SULFANONE INHIBITORS OF ENPP1 Volastra Therapeutics, Inc. (US) 2023-03-15 EP disclosed